Levalbuterol Solution
Product Images NDC 67296-2271

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 67296-2271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 Ct Cards Carton (Rpsc0189 0.31mg 25 Ct Cards Carton)

This is the packaging label for Levalbuterol Inhalation Solution, USP 0.31 mg/3 mL by Ritedose Pharmaceuticals. It is indicated for oral inhalation only with product NDC 76204-700-55. The label features green shaded banners with dosage strength and product name, plus usage warnings and barcodes.*

FDA Label Image

25 Ct Brick Carton (Rpsc0190 0.31mg 25 Ct Brick Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 0.31 mg/3 mL, a respiratory inhalation solution by Redpharm Drug. The label includes dosage strength, a barcode, the NDC 67296-2271, and instructions for storage and use. The design features green and black text on a white background with the Ritexase Pharmaceuticals logo.*

FDA Label Image

25 Ct Cards Carton (Rpsc0193 0.63mg 25 Ct Cards Carton)

Box packaging label for Levalbuterol Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals. The label indicates it is a respiratory inhalation solution for oral use only. The NDC on the label is 76204-800-55, and the package contains 25 x 3 mL single-dose vials.*

FDA Label Image

25 Ct Brick Carton (Rpsc0194 0.63mg 25 Ct Brick Carton)

Flattened packaging label for Levalbuterol Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals. The label includes dosage strength, NDC 76204-800-25, instructions for storage and use, and manufacturer details. The design features an orange and white color scheme with black text and barcodes.*

FDA Label Image

25 Ct Cards Carton (Rpsc0197 1.25mg 25 Ct Cards Carton)

The packaging label shows Levalbuterol Inhalation Solution, USP with a strength of 1.25 mg (0.042%) in 3 mL. The label is for oral inhalation only and includes barcodes and the manufacturer name, Ritedose Pharmaceuticals. The NDC number displayed is 76204-900-55. The label features red and white color accents.*

FDA Label Image

25 Ct Brick Carton (Rpsc0198 1.25 mg 25 Ct Brick Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 1.25 mg (0.042%) per 3 mL unit-dose vial. The label includes product information, storage instructions, and manufacturer details for Ritedose Pharmaceuticals, LLC. The label is primarily white with red bands and black text, featuring barcodes and NDC number 76204-900-25.*

FDA Label Image

30 Ct Singles Carton (Rpsc0290 0.31mg 30 Ct Singles Carton)

Label for Levalbuterol Inhalation Solution, USP 0.31 mg/3 mL. The label shows this respiratory (inhalation) solution in single-dose vials, with the NDC 76204-700-01 and manufactured by Ritedose Pharmaceuticals. The packaging includes dosage strength and usage instructions, emphasizing it is for oral inhalation only.*

FDA Label Image

30 Ct Singles Carton (Rpsc0291 0.63mg 30 Ct Singles Carton)

Levalbuterol Inhalation Solution, USP .63 mg/3 mL is a respiratory inhalation solution packaged in a carton. The label includes the product name, strength, and route of administration. The labeler is Ritedose Pharmaceuticals. The packaging has a barcode and usage instructions for oral inhalation only. The product NDC on the label is 76204-800-01.*

FDA Label Image

30 Ct Singles Carton (Rpsc0292 1.25mg 30 Ct Singles Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 1.25 mg/3 mL by Ritedose Pharmaceuticals. The flat layout displays the product name, strength, and dosage form prominently. It includes dosage instructions "For Oral Inhalation Only," NDC number 76204-900-01, barcodes, and illustrations of individual ampules. The label is primarily white with red accents and detailed product information.*

FDA Label Image

Chemical Structure (Levalbuterol 01)

Chemical structure diagram of Levalbuterol Hydrochloride, showing the arrangement of its molecular components including hydroxyl groups and the hydrochloride salt.*

FDA Label Image

Figure 1 (Levalbuterol 02)

A line graph plotting mean change in FEV1 over 8 hours for different treatment groups labeled Lev 1.25, Lev 0.63, Rac 2.5, and PBO, showing respiratory drug efficacy with time in hours on the x-axis and mean change in FEV1 on the y-axis.*

FDA Label Image

Figure 2 (Levalbuterol 03)

Line graph depicting mean change in FEV1 percentage over time (hours) for different dosages of Levalbuterol (Lev 1.25 mg, Lev 0.63 mg), Racemic albuterol (Rac 2.5 mg), and a placebo (PB0). The graph shows respiratory function improvement trends over 8 hours for each treatment group.*

FDA Label Image

Figure 3 (Levalbuterol 04)

A line graph showing mean change in FEV1 (%) over time (hours) for different doses and treatments, labeled as Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25, and Pbo, with data points and lines representing each group across the 4-hour time span.*

FDA Label Image

Figure 4 (Levalbuterol 05)

A line graph showing mean change in FEV1 (%) over time (hours) from 0 to 4 hours for different treatments: Levalbuterol 0.63 mg, Levalbuterol 0.31 mg, Racemic albuterol 2.5 mg and 1.25 mg, and placebo. The graph displays the respiratory drug's effect on lung function compared to placebo, with a horizontal line indicating a 15% change threshold.*

FDA Label Image

Figure A (Levalbuterol 06)

An instructional diagram showing a unit-dose vial with shaded areas indicating the twist-off tab portions on both sides of the vial's neck. The diagram includes labels pointing to the twist-off tabs, clarifying how to open the vial for use.*

FDA Label Image

Figure B (Levalbuterol 07)

An instructional illustration showing the top portion of a sachet or pouch with an arrow pointing downward to a tear notch, labeled 'TEAR AT SEAM,' indicating where to open the package.*

FDA Label Image

Figure C (Levalbuterol 08)

A black and white instructional illustration showing two hands. One hand holds a small vial, and the other hand is twisting or opening the top cap of the vial as indicated by a curved arrow, demonstrating how to open the vial for use.*

FDA Label Image

Figure D (Levalbuterol 09)

An instructional illustration showing a hand holding a vial, positioned above a labeled reservoir, likely demonstrating the transfer or use of a liquid solution.*

FDA Label Image

Figure E1 (Levalbuterol 10)

Illustration showing parts of a respiratory inhalation device labeled as "Mouthpiece" and "Reservoir." The diagram highlights the mouthpiece attachment and the reservoir section of the device used for delivering medication.*

FDA Label Image

Figure E2 (Levalbuterol 11)

An instructional illustration showing a face mask and reservoir attachment, likely for use with an inhalation device. The diagram labels the face mask and the reservoir, indicating their connection in the respiratory medication administration process.*

FDA Label Image

Figure F (Levalbuterol 12)

An illustration showing the connection of nebulizer tubing to a compressor device, labeled respectively. The diagram depicts how the tubing attaches to the compressor for respiratory inhalation therapy.*

FDA Label Image

Figure G1 (Levalbuterol 13)

Illustration showing how to use a respiratory inhalation solution device. The image labels the mouthpiece and reservoir of the inhaler, demonstrating the correct positioning for inhalation.*

FDA Label Image

Figure G2 (Levalbuterol 14b)

An instructional diagram showing a respiratory inhalation device with labeled parts: a face mask and a reservoir. The illustration indicates how the face mask is attached to the reservoir component of the device.*

FDA Label Image

Rdp Logo (Rdp Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.